GoodRx Holdings, Inc. - Common Stock (GDRX)

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Equity / Common Stock
Shares outstanding
98.7M
Number of holders
156
Total 13F shares, excl. options
140M
Shares change
-15.6M
Total reported value, excl. options
$652M
Value change
-$76.3M
Put/Call ratio
0.53
Number of buys
78
Number of sells
-82
Price
$4.67

Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q3 2022

201 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q3 2022.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 140M shares .
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), VANGUARD GROUP INC (7.83M shares), LIGHT STREET CAPITAL MANAGEMENT, LLC (4.19M shares), MARSHALL WACE, LLP (3.62M shares), Silver Lake Group, L.L.C. (3.53M shares), RENAISSANCE TECHNOLOGIES LLC (2.22M shares), Petrus Trust Company, LTA (2.16M shares), MILLENNIUM MANAGEMENT LLC (2.12M shares), BlackRock Inc. (1.8M shares), and Technology Crossover Management X, Ltd. (1.65M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.